Correlation Between Lineage Cell and Regenerx Biopharm

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Lineage Cell and Regenerx Biopharm at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Lineage Cell and Regenerx Biopharm into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Lineage Cell Therapeutics and Regenerx Biopharm In, you can compare the effects of market volatilities on Lineage Cell and Regenerx Biopharm and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Lineage Cell with a short position of Regenerx Biopharm. Check out your portfolio center. Please also check ongoing floating volatility patterns of Lineage Cell and Regenerx Biopharm.

Diversification Opportunities for Lineage Cell and Regenerx Biopharm

0.16
  Correlation Coefficient

Average diversification

The 3 months correlation between Lineage and Regenerx is 0.16. Overlapping area represents the amount of risk that can be diversified away by holding Lineage Cell Therapeutics and Regenerx Biopharm In in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Regenerx Biopharm and Lineage Cell is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Lineage Cell Therapeutics are associated (or correlated) with Regenerx Biopharm. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Regenerx Biopharm has no effect on the direction of Lineage Cell i.e., Lineage Cell and Regenerx Biopharm go up and down completely randomly.

Pair Corralation between Lineage Cell and Regenerx Biopharm

If you would invest  3.30  in Regenerx Biopharm In on August 31, 2024 and sell it today you would earn a total of  0.00  from holding Regenerx Biopharm In or generate 0.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy4.55%
ValuesDaily Returns

Lineage Cell Therapeutics  vs.  Regenerx Biopharm In

 Performance 
       Timeline  
Lineage Cell Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Lineage Cell Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.
Regenerx Biopharm 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Regenerx Biopharm In has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong basic indicators, Regenerx Biopharm is not utilizing all of its potentials. The newest stock price disturbance, may contribute to short-term losses for the investors.

Lineage Cell and Regenerx Biopharm Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Lineage Cell and Regenerx Biopharm

The main advantage of trading using opposite Lineage Cell and Regenerx Biopharm positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Lineage Cell position performs unexpectedly, Regenerx Biopharm can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Regenerx Biopharm will offset losses from the drop in Regenerx Biopharm's long position.
The idea behind Lineage Cell Therapeutics and Regenerx Biopharm In pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.

Other Complementary Tools

Commodity Directory
Find actively traded commodities issued by global exchanges
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA